Cargando…

Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection

INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayavannan, Animamalar, Shantz, Emily, Haidl, Ian D., Wang, Jun, Marshall, Jean S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150091/
https://www.ncbi.nlm.nih.gov/pubmed/37138882
http://dx.doi.org/10.3389/fimmu.2023.1166068
_version_ 1785035291619229696
author Mayavannan, Animamalar
Shantz, Emily
Haidl, Ian D.
Wang, Jun
Marshall, Jean S.
author_facet Mayavannan, Animamalar
Shantz, Emily
Haidl, Ian D.
Wang, Jun
Marshall, Jean S.
author_sort Mayavannan, Animamalar
collection PubMed
description INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contribute to responses to Chlamydia infection and aimed to define human mast cell responses to C. trachomatis. METHODS: Human cord blood-derived mast cells (CBMCs) were exposed to C. trachomatis to assess bacterial uptake, mast cell degranulation, gene expression, and production of inflammatory mediators. The role of formyl peptide receptors and Toll-like receptor 2 (TLR2) were investigated using pharmacological inhibitors and soluble TLR2. Mast cell-deficient mice and littermate controls were used to examine the in vivo role of mast cells in influencing the immune response to Chlamydia infection in the female reproductive tract. RESULTS: C. trachomatis bacteria were taken up by human mast cells but did not replicate efficiently inside CBMCs. C. trachomatis-activated mast cells did not degranulate but maintained viability and exhibited cellular activation with homotypic aggregation and upregulation of ICAM-1. However, they significantly enhanced the gene expression of IL1B, CCL3, NFKB1, CXCL8, and IL6. Inflammatory mediators were produced, including TNF, IL-1β, IL-1RA, IL-6, GM-CSF, IL-23, CCL3, CCL5, and CXCL8. Endocytic blockade resulted in reduced gene expression of IL6, IL1B, and CCL3, suggesting C. trachomatis induced mast cell activation in both extracellular and intracellular locations. The IL-6 response to C. trachomatis was reduced when CBMCs were treated with C. trachomatis coated with soluble TLR2. Mast cells derived from TLR2-deficient mice also demonstrated a reduced IL-6 response to C. muridarum. Five days following C. muridarum infection, mast cell-deficient mice showed attenuated CXCL2 production and significantly reduced numbers of neutrophils, eosinophils, and B cells in the reproductive tract when compared with mast cell-containing littermates. DISCUSSION: Taken together, these data demonstrate that mast cells are reactive to Chlamydia spp. through multiple mechanisms that include TLR2-dependent pathways. Mast cells also play an important role in shaping in vivo immune responses in Chlamydia reproductive tract infection through both effector cell recruitment and modification of the chemokine microenvironment.
format Online
Article
Text
id pubmed-10150091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101500912023-05-02 Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection Mayavannan, Animamalar Shantz, Emily Haidl, Ian D. Wang, Jun Marshall, Jean S. Front Immunol Immunology INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contribute to responses to Chlamydia infection and aimed to define human mast cell responses to C. trachomatis. METHODS: Human cord blood-derived mast cells (CBMCs) were exposed to C. trachomatis to assess bacterial uptake, mast cell degranulation, gene expression, and production of inflammatory mediators. The role of formyl peptide receptors and Toll-like receptor 2 (TLR2) were investigated using pharmacological inhibitors and soluble TLR2. Mast cell-deficient mice and littermate controls were used to examine the in vivo role of mast cells in influencing the immune response to Chlamydia infection in the female reproductive tract. RESULTS: C. trachomatis bacteria were taken up by human mast cells but did not replicate efficiently inside CBMCs. C. trachomatis-activated mast cells did not degranulate but maintained viability and exhibited cellular activation with homotypic aggregation and upregulation of ICAM-1. However, they significantly enhanced the gene expression of IL1B, CCL3, NFKB1, CXCL8, and IL6. Inflammatory mediators were produced, including TNF, IL-1β, IL-1RA, IL-6, GM-CSF, IL-23, CCL3, CCL5, and CXCL8. Endocytic blockade resulted in reduced gene expression of IL6, IL1B, and CCL3, suggesting C. trachomatis induced mast cell activation in both extracellular and intracellular locations. The IL-6 response to C. trachomatis was reduced when CBMCs were treated with C. trachomatis coated with soluble TLR2. Mast cells derived from TLR2-deficient mice also demonstrated a reduced IL-6 response to C. muridarum. Five days following C. muridarum infection, mast cell-deficient mice showed attenuated CXCL2 production and significantly reduced numbers of neutrophils, eosinophils, and B cells in the reproductive tract when compared with mast cell-containing littermates. DISCUSSION: Taken together, these data demonstrate that mast cells are reactive to Chlamydia spp. through multiple mechanisms that include TLR2-dependent pathways. Mast cells also play an important role in shaping in vivo immune responses in Chlamydia reproductive tract infection through both effector cell recruitment and modification of the chemokine microenvironment. Frontiers Media S.A. 2023-04-17 /pmc/articles/PMC10150091/ /pubmed/37138882 http://dx.doi.org/10.3389/fimmu.2023.1166068 Text en Copyright © 2023 Mayavannan, Shantz, Haidl, Wang and Marshall https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Mayavannan, Animamalar
Shantz, Emily
Haidl, Ian D.
Wang, Jun
Marshall, Jean S.
Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title_full Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title_fullStr Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title_full_unstemmed Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title_short Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
title_sort mast cells selectively produce inflammatory mediators and impact the early response to chlamydia reproductive tract infection
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150091/
https://www.ncbi.nlm.nih.gov/pubmed/37138882
http://dx.doi.org/10.3389/fimmu.2023.1166068
work_keys_str_mv AT mayavannananimamalar mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection
AT shantzemily mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection
AT haidliand mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection
AT wangjun mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection
AT marshalljeans mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection